Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-000016-19Phase 4Completed
Phase 4, randomised, double-blind trial of sufentanil in pregnancy (3 arms), sponsored by UZ Brussel. Primary endpoint: Pain during uterine internalization. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-000016-19.